Viral Inactivation - Global Market Outlook (2017-2023)

September 2017 | 191 pages | ID: VDF7DDE10ACEN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Viral Inactivation Market is accounted for $1.99 billion in 2016 and expected to grow at a CAGR of 14.9% to reach $5.29 billion by 2023. Factors such as rapid growth in pharmaceutical and biotechnology industries, strong R&D investments in the life sciences industry, high incidence of chronic diseases and increasing number of new drug launches are driving the market growth. However, the high cost of biologics and biosimilars products, development of expensive equipment for viral inactivation are inhibiting the marketspace.

Based on method, the Alkylating agent method segment is considered as the robust & efficient method for inactivation of variety of enveloped viruses. Alkylating agents are monofunctional or bifunctional. Two mechanisms exist for viral inactivation with alkylating agents. One mechanism involves the modification of proteins, which would cause inhibition of viral cell entry or the release of the genome. Also, Formalin and β-propiolactone (β-PL) are used for inactivation of viruses via chemical reaction along with viral capsid proteins and nucleic acids. Alkylating agents permeate the protein capsid of viruses and chemically inactivate the nucleic acid. The alkylating agent N-acetyl-aziridine is a virus inactivate that has been used in vaccine preparation.

Based on product, the usage of kits and reagents has increased tremendously. Two nucleic acid extraction buffers available commercially are used to inactivate the viral stocks. These are TRIzol® LS reagent (Invitrogen Corp.) and AVL Buffer from the Qiamp viral RNA mini kit (Qiagen). North America has dominated the market during the forecast period due to adoption of many methods by blood testing centre. According to the FDA, 41 novel drugs were approved. Increase in funding has also resulted in growth in number of FDA approvals over the recent years.

Some of the key players in Global Viral Inactivation market are Macopharma SA, Charles River Laboratories International, Inc., Clean Cells Inc., Danaher Corporation, Merck KGAA, Parker Hannifin Corporation, Rad Source Technologies, Inc., SGS SA, Sartorius AG, Texcell, Inc., Viral Inactivated Plasma Systems SA, Wuxi Pharmatech (Cayman) Inc., Shandong Weigao Group Medical Polymer Company Limited, Cerus Corporation, Terumo BCT, Inc, BioReliance, Thermo Fisher Scientific Inc. and Macopharma SA.

Applications Covered:

• Stem cell products
• Cellular & Gene therapy products
• Blood & Blood tissue products
• Vaccines & Therapeutics
• Tissues & Tissue products

Products Covered:

• Viral inactivation accessories
• Systems and Services
• Kits & Reagents

Methods Covered:

• pH Concentration method
• Alkylating agent method
• Solvent detergent method
• Pasteurization
• Radiation method
• Other Methods

End Users Covered:

• Blood banks and Hospitals
• Academic research institutes
• Pharmaceutical and Biotechnology companies
• Contract Research Organizations
• Other End Users

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• UK
• Italy
• France
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• South Korea
• Rest of Asia Pacific
• South America
• Argentina
• Brazil
• Chile
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• UAE
• Qatar
• South Africa
• Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Product Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL VIRAL INACTIVATION MARKET, BY APPLICATION

5.1 Introduction
5.2 Stem cell products
5.3 Cellular & Gene therapy products
5.4 Blood & Blood tissue products
5.5 Vaccines & Therapeutics
5.6 Tissues & Tissue products

6 GLOBAL VIRAL INACTIVATION MARKET, BY PRODUCT

6.1 Introduction
6.2 Viral inactivation accessories
6.3 Systems and Services
6.4 Kits & Reagents

7 GLOBAL VIRAL INACTIVATION MARKET, BY METHOD

7.1 Introduction
7.2 pH Concentration method
7.3 Alkylating agent method
7.4 Solvent detergent method
7.5 Pasteurization
7.6 Radiation method
7.7 Other Methods

8 GLOBAL VIRAL INACTIVATION MARKET, BY END USER

8.1 Introduction
8.2 Blood banks and Hospitals
8.3 Academic research institutes
8.4 Pharmaceutical and Biotechnology companies
8.5 Contract Research Organizations
8.6 Other End Users

9 GLOBAL VIRAL INACTIVATION MARKET, BY GEOGRAPHY

9.1 Introduction
9.2 North America
  9.2.1 US
  9.2.2 Canada
  9.2.3 Mexico
9.3 Europe
  9.3.1 Germany
  9.3.2 U.K
  9.3.3 France
  9.3.4 Italy
  9.3.5 Spain
  9.3.6 Rest of Europe
9.4 Asia Pacific
  9.4.1 Japan
  9.4.2 China
  9.4.3 India
  9.4.4 Australia
  9.4.5 New Zealand
  9.4.6 South Korea
  9.4.7 Rest of Asia Pacific
9.5 South America
  9.5.1 Argentina
  9.5.2 Brazil
  9.5.3 Chile
  9.5.4 Rest of South America
9.6 Middle East & Africa
  9.6.1 Saudi Arabia
  9.6.2 UAE
  9.6.3 Qatar
  9.6.4 South Africa
  9.6.5 Rest of Middle East & Africa

10 KEY DEVELOPMENTS

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 COMPANY PROFILING

11.1 Macopharma SA
11.2 Charles River Laboratories International, Inc.
11.3 Clean Cells Inc.
11.4 Danaher Corporation
11.5 Merck KGAA
11.6 Parker Hannifin Corporation
11.7 Rad Source Technologies, Inc.
11.8 SGS SA
11.9 Sartorius AG
11.10 Texcell, Inc.
11.11 Viral Inactivated Plasma Systems SA
11.12 Wuxi Pharmatech (Cayman) Inc.
11.13 Shandong Weigao Group Medical Polymer Company Limited
11.14 Cerus Corporation
11.15 Terumo BCT, Inc.
11.16 BioReliance
11.17 Thermo Fisher Scientific Inc.
11.18 Macopharma SA

List Of Tables

LIST OF TABLES

Table 1 Global Viral Inactivation Market Outlook, By Region (2014-2023) ($MN)
Table 2 Global Viral Inactivation Market Outlook, By Application (2014-2023) ($MN)
Table 3 Global Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN)
Table 4 Global Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN)
Table 5 Global Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN)
Table 6 Global Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN)
Table 7 Global Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN)
Table 8 Global Viral Inactivation Market Outlook, By Product (2014-2023) ($MN)
Table 9 Global Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN)
Table 10 Global Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN)
Table 11 Global Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN)
Table 12 Global Viral Inactivation Market Outlook, By Method (2014-2023) ($MN)
Table 13 Global Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN)
Table 14 Global Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN)
Table 15 Global Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN)
Table 16 Global Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN)
Table 17 Global Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN)
Table 18 Global Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN)
Table 19 Global Viral Inactivation Market Outlook, By End User (2014-2023) ($MN)
Table 20 Global Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN)
Table 21 Global Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN)
Table 22 Global Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN)
Table 23 Global Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN)
Table 24 Global Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN)
Table 25 North America Viral Inactivation Market Outlook, By Country (2014-2023) ($MN)
Table 26 North America Viral Inactivation Market Outlook, By Application (2014-2023) ($MN)
Table 27 North America Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN)
Table 28 North America Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN)
Table 29 North America Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN)
Table 30 North America Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN)
Table 31 North America Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN)
Table 32 North America Viral Inactivation Market Outlook, By Product (2014-2023) ($MN)
Table 33 North America Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN)
Table 34 North America Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN)
Table 35 North America Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN)
Table 36 North America Viral Inactivation Market Outlook, By Method (2014-2023) ($MN)
Table 37 North America Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN)
Table 38 North America Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN)
Table 39 North America Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN)
Table 40 North America Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN)
Table 41 North America Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN)
Table 42 North America Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN)
Table 43 North America Viral Inactivation Market Outlook, By End User (2014-2023) ($MN)
Table 44 North America Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN)
Table 45 North America Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN)
Table 46 North America Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN)
Table 47 North America Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN)
Table 48 North America Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN)
Table 49 Europe Viral Inactivation Market Outlook, By Country (2014-2023) ($MN)
Table 50 Europe Viral Inactivation Market Outlook, By Application (2014-2023) ($MN)
Table 51 Europe Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN)
Table 52 Europe Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN)
Table 53 Europe Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN)
Table 54 Europe Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN)
Table 55 Europe Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN)
Table 56 Europe Viral Inactivation Market Outlook, By Product (2014-2023) ($MN)
Table 57 Europe Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN)
Table 58 Europe Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN)
Table 59 Europe Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN)
Table 60 Europe Viral Inactivation Market Outlook, By Method (2014-2023) ($MN)
Table 61 Europe Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN)
Table 62 Europe Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN)
Table 63 Europe Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN)
Table 64 Europe Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN)
Table 65 Europe Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN)
Table 66 Europe Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN)
Table 67 Europe Viral Inactivation Market Outlook, By End User (2014-2023) ($MN)
Table 68 Europe Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN)
Table 69 Europe Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN)
Table 70 Europe Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN)
Table 71 Europe Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN)
Table 72 Europe Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN)
Table 73 Asia Pacific Viral Inactivation Market Outlook, By Country (2014-2023) ($MN)
Table 74 Asia Pacific Viral Inactivation Market Outlook, By Application (2014-2023) ($MN)
Table 75 Asia Pacific Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN)
Table 76 Asia Pacific Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN)
Table 77 Asia Pacific Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN)
Table 78 Asia Pacific Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN)
Table 79 Asia Pacific Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN)
Table 80 Asia Pacific Viral Inactivation Market Outlook, By Product (2014-2023) ($MN)
Table 81 Asia Pacific Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN)
Table 82 Asia Pacific Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN)
Table 83 Asia Pacific Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN)
Table 84 Asia Pacific Viral Inactivation Market Outlook, By Method (2014-2023) ($MN)
Table 85 Asia Pacific Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN)
Table 86 Asia Pacific Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN)
Table 87 Asia Pacific Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN)
Table 88 Asia Pacific Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN)
Table 89 Asia Pacific Viral Inactivation Market Outlook, By High-energy light (2014-2023) ($MN)
Table 90 Asia Pacific Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN)
Table 91 Asia Pacific Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN)
Table 92 Asia Pacific Viral Inactivation Market Outlook, By End User (2014-2023) ($MN)
Table 93 Asia Pacific Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN)
Table 94 Asia Pacific Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN)
Table 95 Asia Pacific Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN)
Table 96 Asia Pacific Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN)
Table 97 Asia Pacific Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN)
Table 98 South America Viral Inactivation Market Outlook, By Country (2014-2023) ($MN)
Table 99 South America Viral Inactivation Market Outlook, By Application (2014-2023) ($MN)
Table 100 South America Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN)
Table 101 South America Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN)
Table 102 South America Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN)
Table 103 South America Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN)
Table 104 South America Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN)
Table 105 South America Viral Inactivation Market Outlook, By Product (2014-2023) ($MN)
Table 106 South America Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN)
Table 107 South America Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN)
Table 108 South America Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN)
Table 109 South America Viral Inactivation Market Outlook, By Method (2014-2023) ($MN)
Table 110 South America Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN)
Table 111 South America Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN)
Table 112 South America Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN)
Table 113 South America Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN)
Table 114 South America Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN)
Table 115 South America Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN)
Table 116 South America Viral Inactivation Market Outlook, By End User (2014-2023) ($MN)
Table 117 South America Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN)
Table 118 South America Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN)
Table 119 South America Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN)
Table 120 South America Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN)
Table 121 South America Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN)
Table 122 Middle East & Africa Viral Inactivation Market Outlook, By Country (2014-2023) ($MN)
Table 123 Middle East & Africa Viral Inactivation Market Outlook, By Application (2014-2023) ($MN)
Table 124 Middle East & Africa Viral Inactivation Market Outlook, By Stem cell products (2014-2023) ($MN)
Table 125 Middle East & Africa Viral Inactivation Market Outlook, By Cellular & Gene therapy products (2014-2023) ($MN)
Table 126 Middle East & Africa Viral Inactivation Market Outlook, By Blood & Blood tissue products (2014-2023) ($MN)
Table 127 Middle East & Africa Viral Inactivation Market Outlook, By Vaccines & Therapeutics (2014-2023) ($MN)
Table 128 Middle East & Africa Viral Inactivation Market Outlook, By Tissues & Tissue products (2014-2023) ($MN)
Table 129 Middle East & Africa Viral Inactivation Market Outlook, By Product (2014-2023) ($MN)
Table 130 Middle East & Africa Viral Inactivation Market Outlook, By Viral inactivation accessories (2014-2023) ($MN)
Table 131 Middle East & Africa Viral Inactivation Market Outlook, By Systems and Services (2014-2023) ($MN)
Table 132 Middle East & Africa Viral Inactivation Market Outlook, By Kits & Reagents (2014-2023) ($MN)
Table 133 Middle East & Africa Viral Inactivation Market Outlook, By Method (2014-2023) ($MN)
Table 134 Middle East & Africa Viral Inactivation Market Outlook, By pH Concentration method (2014-2023) ($MN)
Table 135 Middle East & Africa Viral Inactivation Market Outlook, By Alkylating agent method (2014-2023) ($MN)
Table 136 Middle East & Africa Viral Inactivation Market Outlook, By Solvent detergent method (2014-2023) ($MN)
Table 137 Middle East & Africa Viral Inactivation Market Outlook, By Pasteurization (2014-2023) ($MN)
Table 138 Middle East & Africa Viral Inactivation Market Outlook, By Radiation method (2014-2023) ($MN)
Table 139 Middle East & Africa Viral Inactivation Market Outlook, By Other Methods (2014-2023) ($MN)
Table 140 Middle East & Africa Viral Inactivation Market Outlook, By End User (2014-2023) ($MN)
Table 141 Middle East & Africa Viral Inactivation Market Outlook, By Blood banks and Hospitals (2014-2023) ($MN)
Table 142 Middle East & Africa Viral Inactivation Market Outlook, By Academic research institutes (2014-2023) ($MN)
Table 143 Middle East & Africa Viral Inactivation Market Outlook, By Pharmaceutical and Biotechnology companies (2014-2023) ($MN)
Table 144 Middle East & Africa Viral Inactivation Market Outlook, By Contract Research Organizations (2014-2023) ($MN)
Table 145 Middle East & Africa Viral Inactivation Market Outlook, By Other End Users (2014-2023) ($MN)